TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,203 | +270.3% | 336,324 | +276.0% | 0.35% | +272.0% |
| Q2 2023 | $1,405 | -99.9% | 89,438 | -29.7% | 0.09% | -40.4% |
| Q3 2021 | $2,084,000 | +2.9% | 127,237 | +5.8% | 0.16% | +28.9% |
| Q2 2021 | $2,025,000 | -14.3% | 120,310 | -7.0% | 0.12% | -19.9% |
| Q1 2021 | $2,363,000 | -35.7% | 129,425 | -35.9% | 0.15% | -58.9% |
| Q4 2020 | $3,676,000 | +71.2% | 202,002 | +67.9% | 0.37% | +65.3% |
| Q3 2020 | $2,147,000 | +52.7% | 120,322 | +53.4% | 0.22% | +37.0% |
| Q2 2020 | $1,406,000 | – | 78,436 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |